WO2009084069A4 - Solution oculaire avec du lycopène organique - Google Patents

Solution oculaire avec du lycopène organique Download PDF

Info

Publication number
WO2009084069A4
WO2009084069A4 PCT/IT2008/000793 IT2008000793W WO2009084069A4 WO 2009084069 A4 WO2009084069 A4 WO 2009084069A4 IT 2008000793 W IT2008000793 W IT 2008000793W WO 2009084069 A4 WO2009084069 A4 WO 2009084069A4
Authority
WO
WIPO (PCT)
Prior art keywords
compositions according
derivatives
hyaluronic acid
weight
lycopene
Prior art date
Application number
PCT/IT2008/000793
Other languages
English (en)
Other versions
WO2009084069A3 (fr
WO2009084069A2 (fr
Inventor
Leonardo Rescio
Original Assignee
Lio Farmaceutici Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lio Farmaceutici Srl filed Critical Lio Farmaceutici Srl
Publication of WO2009084069A2 publication Critical patent/WO2009084069A2/fr
Publication of WO2009084069A3 publication Critical patent/WO2009084069A3/fr
Publication of WO2009084069A4 publication Critical patent/WO2009084069A4/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention concerne une solution oculaire topique comportant des caroténoïdes, des liposomes, des lipides végétaux /cérasomes, des phospholipides et des agents de viscosité.
PCT/IT2008/000793 2008-01-02 2008-12-23 Solution oculaire avec du lycopène organique WO2009084069A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2008A000003 2008-01-02
IT000003A ITMI20080003A1 (it) 2008-01-02 2008-01-02 Composizioni per uso oftalmico

Publications (3)

Publication Number Publication Date
WO2009084069A2 WO2009084069A2 (fr) 2009-07-09
WO2009084069A3 WO2009084069A3 (fr) 2009-09-17
WO2009084069A4 true WO2009084069A4 (fr) 2009-11-05

Family

ID=40290036

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IT2008/000793 WO2009084069A2 (fr) 2008-01-02 2008-12-23 Solution oculaire avec du lycopène organique

Country Status (2)

Country Link
IT (1) ITMI20080003A1 (fr)
WO (1) WO2009084069A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2563991C2 (ru) * 2009-01-19 2015-09-27 Ликоред Лтд Синергические комбинации каротиноидов и полифенолов
US8802075B2 (en) 2009-02-18 2014-08-12 Eyeon Particle Sciences Llc Bi-functional co-polymer use for opthalmic and other topical and local applications
WO2011138228A1 (fr) * 2010-05-04 2011-11-10 Trb Chemedica Ag Composition aqueuse pour utilisation ophtalmique ou cutanée
ITMI20110849A1 (it) * 2011-05-13 2012-11-14 Farmila Thea Farmaceutici Spa Preparazioni oftalmiche in forma di collirio e loro uso
WO2013096173A1 (fr) * 2011-12-21 2013-06-27 Novartis Ag Lentilles de contact contenant un caroténoïde et leur procédé de fabrication
US9173915B1 (en) * 2014-10-10 2015-11-03 Peter F. Kador Antioxidant eye drops
RU2706704C2 (ru) * 2014-12-19 2019-11-20 Кемин Индастриз, Инк. Внутриглазная доставка биологически активных молекул с использованием ионтофореза
AU2016413933B2 (en) 2016-07-06 2023-06-15 Calm Water Therapeutics Llc Bi-functional co-polymer use for ophthalmic and other topical and local applications
TW202027733A (zh) * 2019-01-16 2020-08-01 臺北醫學大學 含有葉黃素之點眼液組合物
US11754753B2 (en) * 2020-04-27 2023-09-12 Coopervision International Limited Antioxidant contact lens
RU2745124C1 (ru) * 2020-07-02 2021-03-22 Общество с ограниченной ответственностью "МедикалСайнс" Биоактивная композиция на основе сшитой соли гиалуроновой кислоты, содержащая ресвератрол, и способ ее получения
IT202100006839A1 (it) * 2021-03-22 2022-09-22 Omisan Farm S R L Preparato topico oftalmico idrosolubile contenente luteina e relativo metodo di produzione
EP4218717A1 (fr) 2022-02-01 2023-08-02 Laboratoires THEA Composition ophtalmique comprenant du resvératrol pour traiter le syndrome de l' il sec

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE109970T1 (de) * 1987-09-03 1994-09-15 Univ Georgia Res Found Cyclosporin-augenmittel.
US5596011A (en) * 1995-04-06 1997-01-21 Repine; Karen M. Method for the treatment of macular degeneration
US6573299B1 (en) * 1999-09-20 2003-06-03 Advanced Medical Instruments Method and compositions for treatment of the aging eye
US20050065091A1 (en) * 2003-09-18 2005-03-24 Gholam Peyman Stabilized ocular solutions
FR2895257A1 (fr) * 2005-12-22 2007-06-29 Oreal Actif pour le traitement du contour des yeux.

Also Published As

Publication number Publication date
ITMI20080003A1 (it) 2009-07-03
WO2009084069A3 (fr) 2009-09-17
WO2009084069A2 (fr) 2009-07-09

Similar Documents

Publication Publication Date Title
WO2009084069A4 (fr) Solution oculaire avec du lycopène organique
US20070207116A1 (en) Antioxidant compositions for the eye
EP3017808B1 (fr) Gel d'acide hyaluronique hydrosoluble et procédé pour le produire
Sevgi et al. Topical antimicrobials for burn infections–an update
EP1883391B1 (fr) Composition du facteur de croissance epidermique, son procede et son application
EP2775838B1 (fr) Composition antimicrobienne aqueuse contenant des acides de résines de conifères
CN101977589A (zh) 皮肤病学使用的壳聚糖凝胶、其制备方法及其用途
ES2689740T3 (es) Composición de uso tópico sin conservante que comprende ácido hialurónico
Nima et al. Photodynamic inactivation of Streptococcus mutans by curcumin in combination with EDTA
DE102014116903A1 (de) Cineolhaltige Zusammensetzung für die nasale Applikation
KR20210114438A (ko) 약학적 전달 조성물 및 그 용도
CA2937213A1 (fr) Composition comprenant du xylitol et du cholecalciferol pour traitement topique de la peau et des membranes muqueuses
WO2018187617A8 (fr) Compositions et utilisations d'antimicrobiens appliqués localement présentant des performances et une sécurité améliorées
US9364512B1 (en) Aloe vera based vaping compositions
CN112237559A (zh) 一种消毒组合物及其制备方法
CN102342890B (zh) 一种水包油o/w护肤乳液及其制造方法
JP2009203184A (ja) 抗老化性の化粧料組成物
US11801231B2 (en) Oral compositions and methods of use
JP2021006518A (ja) 抗酸化機能を有する眼科用製品
EP2552195B1 (fr) Émulsion huile dans l'eau antimicrobienne
CN103800939B (zh) 一种抗菌愈合功能性敷料及其制备方法
WO2020241681A1 (fr) Composition antibactérienne
US9931428B2 (en) Ophthalmic compositions
NZ596035A (en) METHOD AND COMPOSITION FOR TREATING MACULAR DEGENERATION using 15-keto-prostaglandin such as 13,14-dihydro-15-keto-20-ethyl-prostagladin F2-alpha isopropyl ester
CN103230386B (zh) 一种免洗皮肤手微乳消毒液制剂及其制备方法

Legal Events

Date Code Title Description
NENP Non-entry into the national phase in:

Ref country code: DE

WPC Withdrawal of priority claims after completion of the technical preparations for international publication

Ref document number: MI2008A000003

Country of ref document: IT

Date of ref document: 20100701

Free format text: WITHDRAWN AFTER TECHNICAL PREPARATION FINISHED

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08868584

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 08868584

Country of ref document: EP

Kind code of ref document: A2